Dr Eric Pazo
Biomedical Sciences Research Institute, Ulster University
Professor Johnny Moore FRCOphth, MD and Professor Tara Moore lead the ‘Dry Eye’ research team. Dr. Eric Pazo is currently a PhD candidate within the Vision Science research group. He is based in and funded by the Cathedral Eye Clinic. He is committed in researching the diagnosis, prognosis and treatment of various dry eye related conditions affecting the ocular surface using a novel tri-optic capture system. This tri-optic system comprehensively accesses ocular pathology of patients using thermograph, infrared signature and interferometry (DR-1 grading). Our research is also concurrently invested in patients with dry eye associated with various conditions, including Sjögrens Syndrome and other autoimmune conditions. Dr. Pazo also assesses patients with blepharitis and allergic conjunctivitis. He is accepting new patients for evaluation and longitudinal management of dry eye and dry eye condition that does not respond to conventional treatments.
Refractive laser and IOL surgery can affect the ocular surface and similarly conditions of the ocular surface can have negative impact upon refractive surgery outcomes.
The foremost aim of part of this research is to analyse the reaction and interaction between refractive surgery, the ocular surface and healing processes to ensure that visual recovery and performance can be optimised. With improved understanding of the ocular surface and its effect upon corneal clarity and scarring it is hoped that healing reposes can be regularised between patients to improve consistency of outcome in these highly technically advanced procedures.
In addition, our research team is one of the few institutions in the UK or Ireland to actively research into the basic biology related to the revolutionary corneal cross-linking (CXL) treatment for keratoconus.
In 2012, he completed his medical degree from Tianjin Medical University, one of the largest bases for cancer prevention, treatment, training and research in China. During 2013 for his MRes, he researched on Acetylcholine (ACh) Binding Site at α4/α4 Interface of (α4β2)2α4 Nicotinic Receptor Influences Agonist Sensitivity and how breathlessness (‘dyspnoea’) arises so that more effective drugs can be developed to relieve dyspnoea when the underlying disease can’t be cured.
If Interested in any dry eye studies or suffering from keratoconus or corneal scarring, please call: +44 (0)28 9032 2020 or email: info@cathedraleye.com